trending Market Intelligence /marketintelligence/en/news-insights/trending/vSP-5ditCxw6fwZBIfEkcA2 content esgSubNav
Log in to other products

Login to Market Intelligence Platform


Looking for more?

Contact Us
In This List

Yunnan Hongxiang Q2 profit falls YOY

Amazon e-commerce sales soar amid COVID-19

Gauging Supply Chain Risk In Volatile Times

S&P Global Market Intelligence

Cannabis: Hashing Out a Budding Industry


IFRS 9 Impairment How It Impacts Your Corporation And How We Can Help

Yunnan Hongxiang Q2 profit falls YOY

Yunnan Hongxiang Yixintang Pharmaceutical Co. Ltd. said its normalized net income for the second quarter came to 8 fen per share, a decline of 33.7% from 12 fen per share in the prior-year period.

Normalized net income, which excludes unusual gains or losses on a pre- and after-tax basis, was 42.7 million yuan, a decrease of 11.5% from 48.3 million yuan in the year-earlier period.

The normalized profit margin dropped to 3.4% from 4.7% in the year-earlier period.

Total revenue rose 25.5% year over year to 1.30 billion yuan from 1.03 billion yuan, and total operating expenses rose 28.5% from the prior-year period to 1.23 billion yuan from 956.8 million yuan.

Reported net income grew 5.0% from the prior-year period to 83.4 million yuan, or 16 fen per share, from 79.5 million yuan, or 20 fen per share.

As of Aug. 7, US$1 was equivalent to 6.21 yuan.